News

03 February, 2025 Management / Finance

Ono Pharmaceutical Co., Ltd. Announced 2024 Q3 Financial Results
31 October, 2024 Management / Finance

Ono Pharmaceutical Co., Ltd. Announced 2024 Q2 Financial Results
31 July, 2024 Management / Finance

Ono Pharmaceutical Co., Ltd. Announced 2024 1Q Financial Results
09 May, 2024 Company

Ono Pharmaceutical Co., Ltd. Announced 2023 Full Year Financial Results
22 March, 2024 Licensing

Ono Pharmaceutical Co., Ltd. Enters into Comprehensive Drug Discovery Collaboration Agreement with University of Oxford
14 March, 2024 Licensing

Ono Pharmaceutical Co., Ltd. Enters into a Collaboration Agreement with Sibylla Biotech to Generate Novel Drug Candidates for Neurological Disorders
14 February, 2024 Licensing

Ono Pharmaceutical Co., Ltd. Enters into an Option and Collaboration Agreement with Numab to Develop Multi-specific Antibody NM49
07 February, 2024 Sustainability

Ono Pharmaceutical Co., Ltd. Selected as Highest Rating A-List Company by CDP in Two Categories of “Climate Change” and “Water Security” in CDP 2023
31 January, 2024 Company

Ono Pharmaceutical Co., Ltd. Announced 2023 3Q Financial Results
09 January, 2024 Company

Ono Pharmaceutical Co., Ltd. supports for Disasters Caused by the 2024 Noto Peninsula Earthquake
20 December, 2023 Licensing

Ono Pharmaceutical Co., Ltd. Enters into Research Collaboration with UK Dementia Research Institute
13 December, 2023 Sustainability

Ono Pharmaceutical Co., Ltd. Selected for the DJSI World Index and DJSI Asia Pacific Index for Four Straight Years
01 November, 2023 Company

Ono Pharmaceutical Co., Ltd. Announced 2023 2Q Financial Results
24 October, 2023 Licensing

Ono Pharmaceutical Co., Ltd. Enters into a Research Collaboration Agreement with Turbine to Identify and Validate Novel Therapeutic Targets in Oncology
31 July, 2023 Company

Ono Pharmaceutical Co., Ltd. Announced 2023 1Q Financial Results
30 May, 2023 Company

Announcement of address change
10 May, 2023 Company

Ono Pharmaceutical Co., Ltd. Announced 2022 Full Year Financial Results
23 March, 2023 Licensing

Ono Pharmaceutical Co., Ltd. Enters into a Drug Discovery Collaboration Agreement with Macomics to Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer
17 February, 2023 Company

Ono Pharmaceutical Co., Ltd. Supports for Relief Efforts in the Earthquake in Turkey and Syria
31 January, 2023 Company

Ono Pharmaceutical Co., Ltd. Announced 2022 3Q Financial Results
27 December, 2022 Sustainability

Ono Pharmaceutical Co., Ltd. Selected for the DJSI World Index and DJSI Asia Pacific Index for Three Straight Years
27 December, 2022 Sustainability

Ono Pharmaceutical Co., Ltd. Selected as Highest Rating A-List Company by CDP in Two Categories of “Climate Change” and “Water Security” in CDP 2022
14 December, 2022 Licensing

Ono Pharmaceutical Co., Ltd. Enters into a Multi Target R&D Collaboration Agreement with PrecisionLife
14 November, 2022 Licensing

Ono Pharmaceutical Co., Ltd. Enters a Drug Discovery Collaboration Agreement with Captor Therapeutics to Develop Small Molecule Protein Degraders for the Treatment of Neurodegenerative Diseases
01 November, 2022 Licensing

Ono Pharmaceutical Co., Ltd. Enters a Drug Discovery Collaboration Agreement with Memo Therapeutics to Discover and Develop Antibody Drugs in the Immuno-oncology Field
31 October, 2022 Company

Ono Pharmaceutical Co., Ltd. Announced 2022 2Q Financial Results
01 August, 2022 Company

Ono Pharmaceutical Co., Ltd. Announced 2022 1Q Financial Results
11 May, 2022 Company

Ono Pharmaceutical Co., Ltd. Announced 2021 Full Year Financial Results
31 January, 2022 Company

Ono Pharmaceutical Co., Ltd. Announced 2021 3Q Financial Results
17 January, 2022 Licensing

Ono Pharmaceutical Co., Ltd. Expands Drug Discovery Collaboration with Neurimmune AG in the Field of Neurodegenerative Diseases
15 December, 2021 Sustainability

Ono Pharmaceutical Co., Ltd. Selected as a Highest Rating A-List Company for Both “Climate Change” and “Water Security” in CDP 2021
01 November, 2021 Company

Ono Pharmaceutical Co., Ltd. Announced 2021 2Q Financial Results
06 August, 2021 Licensing

Ono Pharmaceutical Co., Ltd. Entered into Research Collaboration Agreement with Healx Limited
30 July, 2021 Company

Ono Pharmaceutical Co., Ltd. Announced 2021 1Q Financial Results
11 May, 2021 Company

Ono Pharmaceutical Co., Ltd. Announced 2020 Full Year Financial Results
01 February, 2021 Company

Ono Pharmaceutical Co., Ltd. Announces 2020 3Q Financial Results
25 December, 2020 Company

ONO PHARMA UK LTD. launches a new website.(304KB)